Ending respiratory infections

Original Article ↗ Hacker News Discussion ↗

Personal impact and motivation

  • Multiple commenters share serious cases: death from a “mild” virus in an immunocompromised person, frequent severe illness in families with young children, asthma flare-ups and many missed school days, and long COVID leading to disability.
  • These stories are used to push back on “it’s just a cold” attitudes and to justify strong support for ambitious prevention efforts.

How common and burdensome respiratory infections are

  • One claim that healthy people spend ~15–25 days/year sick is hotly debated.
  • Some see it as unbelievable; others (especially with kids, office work, or public transit) say it matches or even underestimates their experience.
  • Distinction is made between “bedridden” vs. any symptoms; some think the number only works if every minor symptom counts.
  • Several report dramatic increases in illness after kids start daycare/school; others report big decreases after remote work or avoiding subways.

Air quality and air-cleaning technologies

  • Many are disappointed society didn’t invest more in ventilation, HEPA filters, and UV after COVID, especially in schools and offices.
  • Some report anecdotal success with home HEPA units reducing illness.
  • Barriers cited: cost to building owners, unclear ROI, invisible benefits (“nothing happens when it works”), and technical challenges in dense environments like subways.

Feasibility and strategy skepticism

  • Some are excited by the moonshot framing; others doubt biology will yield to money as predictably as rocketry.
  • Critiques of comparing air and water: water is centralized and controllable; air is diffuse and ubiquitous.
  • A few worry the plan may be strategically flawed even with good execution; “ending” respiratory infections is seen as possibly unrealistic.

Funding, economics, and incentives

  • $500M is seen as both large (for a risky bet) and tiny compared to NASA or wars.
  • Debate over whether philanthropy is a good substitute for public funding; some argue market incentives favor ongoing treatment over true cures.
  • Others note opportunity cost versus cheaper global health interventions (malnutrition, basic disease control).

Vaccines and self-spreading concepts

  • Interest is expressed in contagious/self-replicating vaccines, but most replies raise ethical, consent, and bioweapon concerns and doubt public acceptance.
  • Standard vaccines are viewed as underused due to misinformation and logistics, not lack of technology.

Lifestyle and regulatory measures

  • Some argue that diet, exercise, sleep, and stress reduction can greatly cut illness; others counter that this does not make one immune to flu or kid-borne pathogens.
  • Proposals include sugar/alcohol/nicotine taxes and stricter pollution controls; implementation costs and political obstacles are acknowledged.